Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Misregulation of PPAR Functioning and Its Pathogenic Consequences Associated with Nonalcoholic Fatty Liver Disease in Human Obesity
Authors
Keywords
-
Journal
PPAR Research
Volume 2012, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2012-12-10
DOI
10.1155/2012/107434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TNF-α inhibits PPARβ/δ activity and SIRT1 expression through NF-κB in human adipocytes
- (2012) Lucía Serrano-Marco et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Dorothy Hodgkin Lecture 2012* Non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management
- (2012) C. D. Byrne DIABETIC MEDICINE
- Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes
- (2012) Fabrizio Damiano et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- PPAR and Oxidative Stress: Con() Catenating NRF2 and FOXO
- (2012) Simone Polvani et al. PPAR Research
- New Insights into the Role of Peroxisome Proliferator-Activated Receptors in Regulating the Inflammatory Response after Tissue Injury
- (2012) Miriam D. Neher et al. PPAR Research
- Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
- (2011) Yun-Jung Choi et al. ATHEROSCLEROSIS
- Roles of PPARs in NAFLD: Potential therapeutic targets
- (2011) Anne Tailleux et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- A review of the mammalian unfolded protein response
- (2011) Anirikh Chakrabarti et al. BIOTECHNOLOGY AND BIOENGINEERING
- Genetic Variation in the Peroxisome Proliferator Activated Receptor-Gamma Gene Is Associated with Histologically Advanced NAFLD
- (2011) Samer Gawrieh et al. DIGESTIVE DISEASES AND SCIENCES
- Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
- (2011) Michael R. Charlton et al. GASTROENTEROLOGY
- Glutathione- and non-glutathione-based oxidant control in the endoplasmic reticulum
- (2011) C. Appenzeller-Herzog JOURNAL OF CELL SCIENCE
- Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
- (2011) Esther M. M. Ooi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
- (2011) Harold E. Bays et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Up-Regulation of PPAR-γ mRNA Expression in the Liver of Obese Patients: an Additional Reinforcing Lipogenic Mechanism to SREBP-1c Induction
- (2011) Paulina Pettinelli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2011) Helen M. Parker et al. JOURNAL OF HEPATOLOGY
- PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population
- (2011) Zhen Yang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- From chronic overfeeding to hepatic injury: Role of endoplasmic reticulum stress and inflammation
- (2011) M.P. Mollica et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Hepatic n-3 Polyunsaturated Fatty Acid Depletion Promotes Steatosis and Insulin Resistance in Mice: Genomic Analysis of Cellular Targets
- (2011) Barbara D. Pachikian et al. PLoS One
- The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity
- (2011) Rodrigo Valenzuela et al. Food & Function
- Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease
- (2010) Christopher L. Gentile et al. BIOFACTORS
- Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study
- (2010) Paola Dongiovanni et al. BMC GASTROENTEROLOGY
- Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
- (2010) Gökhan S. Hotamisligil CELL
- PPARs: diverse regulators in energy metabolism and metabolic diseases
- (2010) Yong-Xu Wang CELL RESEARCH
- Liver NF-κB and AP-1 activation and PPAR-α expression are negatively correlated in obese patients: Pro-inflammatory implications
- (2010) Luis A. Videla CLINICAL NUTRITION
- The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease
- (2010) Haim Shapiro et al. CLINICAL NUTRITION
- Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
- (2010) Sihao Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Endoplasmic reticulum stress in liver disease
- (2010) Harmeet Malhi et al. JOURNAL OF HEPATOLOGY
- Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease
- (2010) Juan G. Gormaz et al. PROGRESS IN LIPID RESEARCH
- Peroxisome Proliferator-Activated Receptor Alpha Target Genes
- (2010) Maryam Rakhshandehroo et al. PPAR Research
- Enhancement in liver SREBP-1c/PPAR-α ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion
- (2009) Paulina Pettinelli et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease
- (2009) Baukje de Roos et al. BRITISH JOURNAL OF PHARMACOLOGY
- Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma
- (2009) KyeongJin Kim et al. FEBS LETTERS
- Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis
- (2009) Naoki Tanaka et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome
- (2009) Raffaele Marfella et al. JOURNAL OF LIPID RESEARCH
- Decreased Liver Fatty Acid Δ-6 and Δ-5 Desaturase Activity in Obese Patients
- (2009) Julia Araya et al. Obesity
- Liver NF-κB and AP-1 DNA Binding in Obese Patients
- (2009) Luis A. Videla et al. Obesity
- Comparative Analysis of Gene Regulation by the Transcription Factor PPARα between Mouse and Human
- (2009) Maryam Rakhshandehroo et al. PLoS One
- Gene expression in human NAFLD
- (2008) Dario Greco et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Post-translational modifications of adiponectin: mechanisms and functional implications
- (2008) Yu Wang et al. BIOCHEMICAL JOURNAL
- NF-κB and cancer—identifying targets and mechanisms
- (2008) Willscott E Naugler et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- N-3 polyunsaturated fatty acid regulation of hepatic gene transcription
- (2008) Donald B Jump CURRENT OPINION IN LIPIDOLOGY
- Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss
- (2008) M. F. Gregor et al. DIABETES
- Increase in Endoplasmic Reticulum Stress-Related Proteins and Genes in Adipose Tissue of Obese, Insulin-Resistant Individuals
- (2008) G. Boden et al. DIABETES
- Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
- (2008) Anna Ludovica Fracanzani et al. HEPATOLOGY
- Endoplasmic Reticulum Stress Markers Are Associated with Obesity in Nondiabetic Subjects
- (2008) Neeraj K. Sharma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Val227Ala substitution in the peroxisome proliferator activated receptor alpha (PPAR alpha) gene associated with non-alcoholic fatty liver disease and decreased waist circumference and waist-to-hip ratio
- (2008) Shaohua Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Integration of metabolism and inflammation by lipid-activated nuclear receptors
- (2008) Steven J. Bensinger et al. NATURE
- Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities
- (2008) Inki Kim et al. NATURE REVIEWS DRUG DISCOVERY
- Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)
- (2008) G MUSSO et al. PROGRESS IN LIPID RESEARCH
- Abnormalities of Lipid Metabolism in Nonalcoholic Fatty Liver Disease
- (2008) Onpan Cheung et al. SEMINARS IN LIVER DISEASE
- Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease
- (2008) Maryam Kashi et al. SEMINARS IN LIVER DISEASE
- Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease
- (2008) Eric R Kallwitz et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia
- (2008) Feng-Shang Zhu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease
- (2007) L. Spadaro et al. DIGESTIVE AND LIVER DISEASE
- Activation and Dysregulation of the Unfolded Protein Response in Nonalcoholic Fatty Liver Disease
- (2007) Puneet Puri et al. GASTROENTEROLOGY
- Alterations in Adipose Tissue and Hepatic Lipid Kinetics in Obese Men and Women With Nonalcoholic Fatty Liver Disease
- (2007) Elisa Fabbrini et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Potential for Nuclear Receptors as Therapeutic Targets
- (2007) Jacob George et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started